Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taron

Showing results (251-260 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer GroupJosé Luis Ramirez, Rafael Rosell, Miquel Taron, et al.
BMC Cancer|May 16, 2016
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancerLaura Bonanno, Carlota Costa, Margarita Majem, et al.
Journal of the National Cancer Institute|August 25, 2011
mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancerJia Wei, Carlota Costa, Yitao Ding, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Application of post glycosylation modifying enzymes for mass spectrometry imaging of modified <i>N</i>-glycans <i>in situ</i>Julia E Dreifus, Léa Chuzel, Edwin E Escobar, et al.
Research Square|December 11, 2023
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
Journal for Immunotherapy of Cancer|July 11, 2023
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancerZsofia Dora Drobni, Carlos Gongora, Jana Taron, et al.
Journal of the American Society for Mass Spectrometry|April 28, 2026
Application of Post-Glycosylation Modifying Enzymes for Mass Spectrometry Imaging of Modified <i>N</i>-Glycans <i>In Situ</i>Julia E Dreifus, Léa Chuzel, Edwin E Escobar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 31, 2013
Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibilityA Cebrián, M Taron, N Sala, et al.
The Journal of Biological Chemistry|November 9, 2023
A novel family of sugar-specific phosphodiesterases that remove zwitterionic modifications of GlcNAcSamantha L Fossa, Brian P Anton, Daniel W Kneller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancerA Font, M Taron, J L Gago, et al.
Pageof 34

Showing results (251-260 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer GroupJosé Luis Ramirez, Rafael Rosell, Miquel Taron, et al.
BMC Cancer|May 16, 2016
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancerLaura Bonanno, Carlota Costa, Margarita Majem, et al.
Journal of the National Cancer Institute|August 25, 2011
mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancerJia Wei, Carlota Costa, Yitao Ding, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Application of post glycosylation modifying enzymes for mass spectrometry imaging of modified <i>N</i>-glycans <i>in situ</i>Julia E Dreifus, Léa Chuzel, Edwin E Escobar, et al.
Research Square|December 11, 2023
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodiesMiyo K Chatanaka, Lisa M Avery, Maria D Pasic, et al.
Journal for Immunotherapy of Cancer|July 11, 2023
Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancerZsofia Dora Drobni, Carlos Gongora, Jana Taron, et al.
Journal of the American Society for Mass Spectrometry|April 28, 2026
Application of Post-Glycosylation Modifying Enzymes for Mass Spectrometry Imaging of Modified <i>N</i>-Glycans <i>In Situ</i>Julia E Dreifus, Léa Chuzel, Edwin E Escobar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 31, 2013
Variants in phospholipid metabolism and upstream regulators and non-small cell lung cancer susceptibilityA Cebrián, M Taron, N Sala, et al.
The Journal of Biological Chemistry|November 9, 2023
A novel family of sugar-specific phosphodiesterases that remove zwitterionic modifications of GlcNAcSamantha L Fossa, Brian P Anton, Daniel W Kneller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2010
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancerA Font, M Taron, J L Gago, et al.
Pageof 34